Mortality, Recurrence, and Dependency Rates Are Higher after Acute Ischemic Stroke in Elderly Patients with Diabetes Compared to Younger Patients by Xue Long et al.
fnagi-08-00142 June 14, 2016 Time: 13:46 # 1
ORIGINAL RESEARCH
published: 16 June 2016
doi: 10.3389/fnagi.2016.00142
Edited by:
Ying Xu,
The State University of New York
at Buffalo, USA
Reviewed by:
Maria Markaki,
Foundation for Research
and Technology – Hellas, Greece
Vijay Karkal Hegde,
Texas Tech University, USA
*Correspondence:
Bin Li
libin_1971_2008@sina.com;
Zhongping An
tjhhazp@sina.com;
Jinghua Wang
jhw8799@yahoo.com
Received: 06 April 2016
Accepted: 30 May 2016
Published: 16 June 2016
Citation:
Long X, Lou Y, Gu H, Guo X,
Wang T, Zhu Y, Zhao W, Ning X, Li
B, Wang J and An Z (2016) Mortality,
Recurrence, and Dependency Rates
Are Higher after Acute Ischemic Stroke
in Elderly Patients with Diabetes
Compared to Younger Patients.
Front. Aging Neurosci. 8:142.
doi: 10.3389/fnagi.2016.00142
Mortality, Recurrence, and
Dependency Rates Are Higher after
Acute Ischemic Stroke in Elderly
Patients with Diabetes Compared to
Younger Patients
Xue Long1,2, Yongzhong Lou1, Hongfei Gu1, Xiaofei Guo1, Tao Wang1, Yanxia Zhu1,
Wenjuan Zhao3, Xianjia Ning4,5, Bin Li1,2*, Jinghua Wang4,5* and Zhongping An3*
1 Department of Neurology, Tianjin Haibin People’s Hospital, Tianjin, China, 2 The Graduate School, Tianjin University of
Traditional Chinese Medicine, Tianjin, China, 3 Department of Neurology, Tianjin Huanhu Hospital, Tianjin, China,
4 Department of Neurology, Tianjin Medical University General Hospital, Tianjin, China, 5 Department of Epidemiology, Tianjin
Neurological Institute, Tianjin, China
Stroke has a greater effect on the elderly than on younger patients. However, the
long-term outcomes associated with stroke among elderly patients with diabetes are
unknown. We aimed to assess the differences in long-term outcomes between young
and elderly stroke patients with diabetes. A total of 3,615 acute ischemic stroke patients
with diabetes were recruited for this study between 2006 and 2014. Outcomes at 12
and 36 months after stroke (including mortality, recurrence, and dependency) were
compared between younger (age <75 years) and elderly (age ≥75 years) patients.
The elderly group included 692 patients (19.1%) overall. Elderly patients were more
likely than younger patients to have a Trial of Org 10172 in Acute Stroke Treatment
classification of stroke due to cardioembolism, moderate and severe stroke, and atrial
fibrillation, but less likely to have hypertension and dyslipidemia, current smokers, and
alcohol consumers. Mortality, dependency, and recurrence rates at 12 months after
stroke were 19.0, 48.5, and 20.9% in the elderly group and 7.4, 30.9, and 15.4% in
the younger group, respectively (all P < 0.05). Corresponding rates at 36 months after
stroke were 35.4, 78.7, and 53.8% in the elderly group and 13.7, 61.7, and 43.0% in the
younger group, respectively (all P < 0.001). The mortality, dependency, and recurrence
rates at 12 and 36 months after stroke were significantly higher in the elderly group than
in the younger group after adjusting for stroke subtypes, stroke severity, and risk factors.
Odds ratios (95% confidence interval) at 12 and 36 months after stroke were 2.18 (1.64–
2.89) and 3.10 (2.35–4.08), respectively, for mortality, all P < 0.001; 1.81 (1.49–2.20)
and 2.04 (1.57–2.34), respectively, for dependency, all P < 0.001; and 1.37 (1.06–1.76)
and 1.40 (1.07–1.85), respectively, for recurrence, P = 0.016. The findings from this
study suggest that management and secondary prevention should be emphasized in
elderly patients with diabetes in China to reduce mortality, recurrence, and dependency
after stroke.
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INTRODUCTION
Age is the most important non-modifiable risk factor for
all subtypes of stroke, particularly ischemic stroke (MONICA
Project (Monitoring Trends Determinants in Cardiovascular
Disease), 1988; Feigin et al., 2014). The incidence of stroke
more than doubles in each successive decade after the age of
55 years (MONICA Project (Monitoring Trends Determinants
in Cardiovascular Disease), 1988). The age-standardized stroke
incidence in low- and middle-income countries exceeds that in
high-income countries by 21% in individuals ≥75 years old, and
age-standardized stroke mortality exceeds that in high-income
countries by 33%. In addition, the number of lost disability-
adjusted life-years is 1.5 times higher in low- and middle-
income countries (Rothwell et al., 2005). China has experienced
significant growth in its elderly population in recent decades;
those≥75 years old accounted for 3.5% of the population in 2013,
and there were 200 million elderly residents≥65 years old in 2014
(National Bureaus of Statistics of the People’s Republic of China,
2014; Peilin et al., 2014).
Population-based studies have indicated that 65% of all strokes
occur in individuals>65 years old (MONICA Project (MONICA
Project (Monitoring Trends Determinants in Cardiovascular
Disease), 1988; Lloyd-Jones et al., 2009). Moreover, elderly
patients have worse functional outcomes after stroke than
do younger patients, and these differences persist even after
adjusting for stroke risk factors and other comorbidities (Di
Carlo et al., 1999; Kelly-Hayes et al., 2003; Bhalla et al., 2004;
Kammersgaard et al., 2004; Palnum et al., 2008). A population-
based study demonstrated that the incidence of first-ever stroke
increased by 4.3% annually in China among those ≥65 years old
from 1992 to 2012 (Wang et al., 2015).
It is well known that diabetes is significantly associated
with stroke, and patients with diabetes mellitus (DM) are
at greater risk of stroke than individuals without diabetes
(Brott et al., 1989; Recommendations on Stroke Prevention,
Diagnosis, and Therapy, 1989; Ullberg et al., 2015). A few
studies have investigated the association between DM and long-
term prognosis of patients following acute ischemic stroke
(AIS; Rankin, 1957; Mahoney and Barthel, 1965); however, the
FIGURE 1 | Flow diagram of patients’ selection.
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evidence for this association among elderly patients remains
controversial. A report from China demonstrated that DM
independently predicted poor outcomes within 6 months after
AIS in Chinese patients (Wang et al., 2013). However, differences
in long-term outcomes among elderly stroke patients with DM
have not been established.
Therefore, in this study, we aimed to evaluate differences in
long-term outcomes between younger patients (<75 years old)
and elderly patients (≥75 years old) with diabetes following AIS
from a hospital-based stroke registry in Tianjin, China.
MATERIALS AND METHODS
All consecutive patients with AIS who were hospitalized in
three stroke units in Tianjin, China between January 2006
and September 2014 were recruited for this study. Stroke was
defined according to the World Health Organization’s criteria,
and a diagnosis of AIS was confirmed in all patients based
on neuroimaging evidence (Banks and Marotta, 2007). Those
patients diagnosed with transient ischemic attack were excluded.
DM was defined by a previous or new-onset physician diagnosis
of DM, or use of hypoglycemic medications.
The ethics committee of Tianjin Medical University General
Hospital approved the study, and patients or their next of
kin provided written informed consent for participation in
accordance with the Declaration of Helsinki.
Data were collected prospectively according to a standardized
procedure. Ischemic stroke subtypes, neurological deficits, level
of disability at the time of admission, stroke severity, and
stroke risk factors were recorded. Levels of total cholesterol
(TC), triglycerides (TG), high-density lipoprotein cholesterol
(HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting
glucose (FG), and glycosylated hemoglobin (HbA1) at admission
also were recorded. During the follow-up period, data on AIS
outcomes, including all-cause death, dependency, and recurrence
were assessed.
According to the Trial of Org 10172 in Acute Stroke
Treatment (TOAST) criteria, ischemic stroke subtypes were
classified according to etiology as stroke due to large artery
atherothrombosis (LAA), stroke due to cardioembolism (CE),
stroke due to small artery occlusion (SAO), stroke of other
determined etiology, and stroke of undetermined etiology
(Murray and Lopez, 1997). Neurological deficits were assessed
using the National Institutes of Health stroke scale (NIHSS;
Marini et al., 2004), and the level of disability was measured using
the Barthel index (BI; Gur et al., 2012) and modified Rankin
scale (mRS; Olindo et al., 2003). Stroke severity was categorized
into three groups based on the NIHSS score: mild (NIHSS: ≤7),
moderate (NIHSS: 8–16), and severe (NIHSS: ≥17) (Deng et al.,
2012).
Risk factors for stroke included a medical history of
hypertension, dyslipidemia, atrial fibrillation (AF), and obesity
(body mass index ≥30 kg/m2); and modifiable lifestyle factors,
including current smoking status and alcohol consumption.
Outcome measures for stroke were mortality, recurrence, and
dependency rates 12 and 36 months after AIS. Death was defined
TABLE 1 | Demographical and clinical characteristics in ischemic stroke
patients with DM by age.
Characteristics Younger group Elderly group P
Gender, n (%): 2,923 (80.9) 692 (19.1) <0.001
Men 1,852 (83.3) 371 (16.7)
Women 1,071 (76.9) 321 (23.1)
Total
TOAST classification, n (%):
Atherothrombotic 2,066 (71.1) 467 (68.9) 0.099
Small artery disease 678 (23.3) 139 (20.5) 0.079
Cardiac embolism 73 (2.5) 65 (9.6) <0.0001
Others determined etiology 47 (1.6) 2 (0.3) 0.007
Undetermined etiology 42 (1.4) 5 (0.7) 0.136
Stroke severity, n (%):
Mild 1,918 (65.6) 379 (54.8) <0.0001
Moderate 772 (26.4) 218 (31.5) 0.007
Severe 233 (8.0) 95 (13.7) <0.0001
Neurological function:
NIHSS 6 (6) 7 (9) <0.001
BI 60 (50) 50 (50) <0.001
mRS 3 (2) 4 (1) <0.001
Laboratory examination:
Total cholesterol 5.04 (1.13) 5.01 (1.20) 0.533
Triglyceride 1.93 (1.44) 1.56 (0.84) <0.001
High-density lipoprotein cholesterol 1.01 (0.25) 1.05 (0.26) <0.001
Low-density lipoprotein cholesterol 3.10 (0.88) 3.11 (0.94) 0.668
TABLE 2 | The prevalence of risk factors in ischemic stroke patients with
DM by age.
Previous history of
diseases and risk factors
Younger group Elderly group P
Hypertension 2,298 (78.6) 515 (74.4) 0.017
Atrial fibrillation 144 (4.9) 94 (13.6) <0.00001
Artery stenosis 804 (27.5) 186 (26.9) 0.739
Dyslipidemias 1,135 (38.8) 202 (29.2) <0.001
Obesity 487 (16.7) 130 (18.8) 0.182
Current smoking 1,078 (36.9) 110 (15.9) <0.001
Alcohol consumption 522 (17.9) 32 (4.6) <0.001
as all-cause mortality at the corresponding time points after
hospital admission. Stroke recurrence was defined as any new-
onset vascular event, including stroke, myocardial infarction, and
venous thrombosis, at least 30 days after stroke. Dependency was
defined as an mRS score ≥3 (Fonarow et al., 2010). Mortality
rates at 12 and 36 months after AIS were calculated as the
number of all-cause deaths within 12 and 36 months divided by
the total number of patients at the corresponding time points.
The recurrence rate was calculated as the proportion of patients
with new-onset vascular events, including patients who died of
vascular events, during the follow-up period. The dependency
rate was calculated as the number of patients with an mRS score
≥3 divided by the total number of stroke survivors at 12 and
36 months after AIS.
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All patients were categorized into two groups by age: younger
group (<75 years old) and elderly group (≥75 years old). All
continuous variables, which included age, NIHSS, BI, mRS, and
laboratory values (TC, TG, HDL-C, LDL-C, FG, and HbA1)
are presented as the mean (standard deviation) or median
(interquartile range, IQR) and compared between groups using
the Student’s t-test or Mann–Whitney U test. All categorical
variables, including ischemic stroke subtype, stroke severity, and
stroke risk factors, are presented as the number (percentage);
the differences between groups for categorical variables were
analyzed using the Chi-squared test. A multivariate logistic
regression analysis was performed to assess factors associated
with stroke outcomes by adjusting for covariates (including
stroke subtype, severity, and risk factors). The results of the
multivariate analysis are presented as adjusted odds ratios (ORs)
with 95% confidence intervals (CIs). All statistical analyses were
performed using SPSS version 15.0 (SPSS Inc., Chicago, IL,
USA), and P-values <0.05 resulting from two-tailed tests were
considered statistically significant.
RESULTS
During the study period, 11,330 consecutive patients with AIS
were hospitalized in three stroke units. Of these patients, 7,715
patients (68.1%) were excluded because they did not have DM;
therefore, 3,615 patients (31.9%) were included in the study.
A total of 3,174 patients (94.6%) were analyzed at 12 months after
excluding 181 patients (5.4%) who were lost to follow-up among
3,355 patients with a sufficient follow-up time of 12 months.
Similarly, 2,232 patients (89.0%) were analyzed at 36 months after
excluding 276 patients (11.0%) who were lost to follow-up among
2,508 patients with a sufficient follow-up time of 36 months
(Figure 1).
The elderly group included 692 patients (19.1%), more than
half of whom (53.6%) were men. Elderly patients were more likely
than younger patients to have a TOAST classification of CE (9.6
vs. 2.5%; P< 0.00001). The proportion of patients with moderate
and severe stroke were significantly higher in the elderly group
than in the younger group (31.5 vs. 26.4%, P= 0.007 for moderate
stroke; 13.7 vs 8.0%, P < 0.00001 for severe stroke). Similarly,
median NIHSS and mRS scores were higher, whereas BI scores
were lower, in elderly patients compared with younger patients
(all P < 0.001, Table 1).
The prevalence of hypertension, dyslipidemia, current
smoking, and alcohol consumption was lower in elderly
patients compared to younger patients (Table 2); however, an
opposite trend was observed for the prevalence of AF (13.6 vs.
4.9%, P < 0.001). There were no significant differences in the
prevalence of artery stenosis and obesity between the elderly and
younger patients.
Mortality, dependency, and recurrence rates at 12 months
after stroke were 19.0, 48.5, and 20.9% in the elderly group
and 7.4, 30.9, and 15.4% in the younger group, respectively (all
P< 0.05). The corresponding rates at 36 months after stroke were
35.4, 78.7, and 53.8% in the elderly group and 13.7, 61.7, and
43.0% in the younger group, respectively (all P < 0.001). After
adjusting for stroke subtypes, severity, and risk factors, mortality,
dependency, and recurrence rates at 12 and 36 months after
stroke were significantly higher in the elderly group than in the
younger group. OR (95% CI) at 12 months after stroke was 2.18
(1.64–2.89, P < 0.001) for mortality, 1.81 (1.49–2.20, P < 0.001)
for dependency, and 1.37 (1.06–1.76, P = 0.016) for recurrence,
respectively. The corresponding values at 36 months after stroke
were 3.10 (2.35–4.08, P < 0.001) for mortality, 2.04 (1.57–2.34,
P < 0.001) for dependency, and 1.40 (1.07–1.85, P = 0.016) for
recurrence, respectively (Table 3).
DISCUSSION
In this study, we assessed and compared the outcomes and
associated risk factors at 12 and 36 months after AIS between
younger patients (<75 years old) and elderly patients (≥75 years
old) with DM in China.
Diabetes mellitus is an independent risk factor for ischemic
stroke, as the relative risk of ischemic stroke in patients with
DM is 1.8–6.0 times higher than in patients without DM
(Saposnik et al., 2008). Moreover, the prevalence of DM ranges
from 21 to 44% in patients with AIS (Soares et al., 2011; Li
et al., 2013). The China National Stroke Registry reported a
26.99% prevalence of DM overall (Schulz and Rothwell, 2003).
TABLE 3 | The OR of mortality, recurrence, and dependency at 12 and 36 months after stroke among stroke patients with DM by age∗.
Outcomes Younger group Elderly group Unadjusted Adjusted†
OR (95% CI) P OR (95% CI) P
12 months:
Mortality 189 (7.4) 116 (19.0) 2.95 (2.30–3.79) <0.001 2.18 (1.64–2.89) <0.001
Dependency 786 (30.7) 296 (48.5) 2.13 (1.78–2.55) <0.001 1.81 (1.49–2.20) <0.001
Recurrence 367 (15.4) 102 (20.9) 1.45 (1.14–1.86) 0.003 1.37 (1.06–1.76) 0.016
36 months:
Mortality 248 (13.7) 151 (35.4) 3.44 (2.70–4.36) <0.001 3.10 (2.35–4.08) <0.001
Dependency 1,113 (61.7) 336 (78.7) 2.30 (1.79–2.95) <0.001 2.04 (1.57–2.64) <0.001
Recurrence 636 (43.0) 141 (53.8) 1.54 (1.19–2.01) <0.001 1.40 (1.07–1.85) 0.016
∗OR indicated the risks in elderly group reference as younger group. † Indicated adjusted by gender, stroke subtype, severity, and risk factors.
Frontiers in Aging Neuroscience | www.frontiersin.org 4 June 2016 | Volume 8 | Article 142
fnagi-08-00142 June 14, 2016 Time: 13:46 # 5
Long et al. Outcomes in Elderly Stroke Patients with Diabetes
Consistent with previous studies, we found a 31.9% prevalence
of DM among patients with AIS, which was higher than the
prevalence determined from the China National Stroke Registry.
Different databases of stroke patients between studies may partly
explain differences in the frequency of stroke patients with
DM.
Previous studies have indicated that ischemic stroke greatly
affects the older population (Lovett et al., 2004; Rothwell et al.,
2005; Lloyd-Jones et al., 2009; Feigin et al., 2014). Several studies
have reported different trends in the prevalence of hypertension,
DM, and AF (Olindo et al., 2003; Bhalla et al., 2004; Marini
et al., 2004; Gur et al., 2012) among elderly individuals. A study
based on a multicenter stroke registry in China reported that
patients aged 80 years and older were more likely to have a
stroke with a TOAST classification of CE (11.6%). Furthermore,
there were higher rates of hypertension (72.1%) and AF (23.4%)
and lower rates of DM (17.5%), dyslipidemia (5.6%), current
smoking status (22.8%), and heavy drinking (2.5%) among AIS
patients ≥80 years old compared to patients <80 years old
(Deng et al., 2012). Consistent with these studies, in this study,
elderly patients exhibited different clinical features and stroke risk
factors than younger patients. The proportions of patients with a
TOAST classification of CE, severe stroke, and AF were higher
in the elderly group than in the younger group. Younger patients
were more likely to have a previous history of hypertension and
dyslipidemia and were more likely to be current smokers and
alcohol consumers than elderly patients. However, there was no
significant difference with respect to artery stenosis or obesity
between the two groups.
Previous studies have demonstrated that older patients have
worse outcomes after stroke than do younger patients (Lovett
et al., 2004; Kimura et al., 2005; Palnum et al., 2008; Tu et al.,
2010, 2011). A study conducted in China reported a mortality rate
of 34.78%, a dependency rate of 43.81%, and a recurrence rate
of 36.02% at 12-month follow-up among AIS patients ≥80 years
old (Deng et al., 2012). Another study reported that the 1-year
case-fatality rate and disability rate in patients ≥80 years old
were 33.8 and 37.8%, respectively (Tu et al., 2011). Findings from
a multivariate analysis in another study revealed that TOAST
classification of CE and LAA and moderate and severe stroke
were associated with mortality and recurrence 3 months after
stroke; moderate and severe stroke also were associated with
dependency 3 months after stroke. In addition, moderate and
severe stroke were significantly associated with mortality and
dependency at 12 months (Bereczki et al., 2009).
Several studies have suggested that DM is associated with a
higher stroke mortality rate (Zhang et al., 2008; Soares et al.,
2011), but this association was not observed in other studies
(Tuttolomondo et al., 2008; Weiss et al., 2013). Furthermore,
many studies have indicated that DM was an important predictive
factor for dependency (Zhang et al., 2008; Eriksson et al.,
2012; Tanaka et al., 2013) and recurrence rates (Sun et al.,
2009; Kong et al., 2010; Callahan et al., 2011) following
stroke. However, studies indicated that treatment DM using
antidiabetic before or after stroke onset has a meaningful
effect on stroke outcome in patients with DM comparing those
patients without DM (Kunte et al., 2007; Tziomalos et al., 2015).
Age emerged as a highly significant inverse predictor of good
functional outcome after ischemic stroke, it was independent
of stroke severity, characteristics, and complications. (Knoflach
et al., 2012). This study found that mortality, dependency, and
recurrence rates were significantly higher in the elderly group
than in the younger group among stroke patients with DM
at both 12 and 36 months. The mortality, dependency, and
recurrence rates in the elderly group were 2.2-, 1.8-, and 1.4-
fold higher, respectively, than the corresponding rates in the
younger group at 12 months, and were 3.1-, 2.0-, and 1.4-fold
higher, respectively, than the corresponding rates in the younger
group at 36 months. Age was a predictor of poor long-term
outcomes among stroke patients with DM, it was independent
of the benefit from treatment using antidiabetic. Worse long-
term outcomes in elderly stroke patients with DM may be
explained by the limited application of secondary measures
for stroke prevention and poor health care services for elderly
patients.
There are several limitations to this study. First, all patients
were from the local hospital in Tianjin, China, resulting in a
limited representation of the general population. Second, all
patients were from the local university hospital or neurological
specialty hospital, and accordingly, the proportion of patients
with severe stroke was higher in this study than in previous
studies. However, we adjusted the results by gender, stroke
subtype, stroke severity, and risk factors in the multivariate
analysis, thus addressing the effect of stroke severity on patient
outcomes in our results. Third, pre-stroke information, including
medication usage and complications such as pneumonia and
urinary tract infection, were not analyzed in this study; therefore,
we were unable to assess the impact of these factors on outcomes
among elderly patients.
CONCLUSION
This is the first study to assess the long-term (12 and
36 months) outcomes following AIS between younger and elderly
AIS patients with DM in China. Mortality, dependency, and
recurrence rates were significantly higher in the elderly group
than in the younger group at both 12 and 36 months after AIS.
The relationship between age and outcomes remained even after
adjusting for stroke subtypes, severity, and risk factors. Age was
a predictor of poor long-term outcomes among stroke patients
with DM, it was independent of the benefit from treatment using
antidiabetic. Poor outcomes in elderly patients may be partly
explained by the higher frequency of women, less frequent use
of secondary measures to prevent stroke, and poor health care
within the elderly population. Thus, management and secondary
prevention should be emphasized in elderly patients with DM
in China to reduce mortality, recurrence, and dependency after
stroke.
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